Target intelligence / Profile preview

Metal-dependent amoebic enzymes

Molecular classification
Enzyme, Metalloenzyme
01

Overview

Metal-dependent amoebic enzymes are a diverse group of proteins within protozoan parasites, most notably Entamoeba histolytica, that require divalent metal cations like iron (Fe2+), zinc (Zn2+), or magnesium (Mg2+) to function as catalytic cofactors (PubMed: 15612913). These enzymes play pivotal roles in the parasite's survival, including energy metabolism via iron-dependent alcohol dehydrogenase (EhADH2) and protection against oxidative stress through iron-superoxide dismutase (Fe-SOD) (PubMed: 10411745). The therapeutic strategy targeting these enzymes involves the use of luminal amebicides like iodoquinol and clioquinol, which act as chelating agents. By binding to essential metal ions in the intestinal lumen, these drugs deprive the parasite of the cofactors necessary for enzyme activity, effectively inhibiting metabolic processes and leading to the death of the trophozoites (StatPearls: NBK546644). This target is primarily relevant for treating asymptomatic carriers of E. histolytica or as a follow-up to systemic treatment for invasive amebiasis to ensure the clearance of luminal parasites. However, the use of drugs targeting this system is limited by potential neurotoxicity, such as subacute myelo-optic neuropathy (SMON) associated with clioquinol (PubMed: 11526243).

Other names
Amoebic metalloenzymesMetal-dependent enzymes of Entamoeba histolyticaEssential metal ions in intestinal lumenLuminal amebicide targets
02

Mechanism of action

Chelation of essential divalent metal ions (e.g., iron, zinc, copper) in the intestinal lumen, which deprives the parasite of necessary cofactors and inhibits the activity of metal-dependent enzymes essential for its survival (StatPearls: NBK546644).

03

Biological functions

MetabolismRedox homeostasisProteolysisCofactor bindingEnergy production
04

Disease associations

AmebiasisInfection
05

Safety considerations

Subacute myelo-optic neuropathy (SMON)Iodism (iodine toxicity)Optic atrophyInterference with thyroid function testsPeripheral neuropathy
06

Interacting drugs

Iodoquinol

1 more in the full profile.

07

Biomarkers

Entamoeba histolytica trophozoites in stoolEntamoeba histolytica cysts in stoolEntamoeba histolytica fecal antigenEntamoeba histolytica DNA (PCR)

Beyond the preview

Go deeper on Metal-dependent amoebic enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metal-dependent amoebic enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call